Showing 5,141 - 5,160 results of 9,864 for search '"drug"', query time: 0.11s Refine Results
  1. 5141

    Simple Ion Transfer at Liquid|Liquid Interfaces by L. J. Sanchez Vallejo, J. M. Ovejero, R. A. Fernández, S. A. Dassie

    Published 2012-01-01
    “…Finally, many practical applications can be envisaged regarding the determination of physicochemical properties, electroanalysis, drug lipophilicity, and phase-transfer catalysis.…”
    Get full text
    Article
  2. 5142

    Profil Bakteri Patogen dan Kepekaannya pada Pasien Ventilator Associated Pneumonia dengan Infeksi COVID- 19 di Rumah Sakit UKRIDA¬ by Jeremy Christopher, Ade Dharmawan, Donna Mesina Pasaribu, Nicolas Layanto

    Published 2023-04-01
    “…The emergence of multi-drug resistant (MDR) bacteria during the pandemic presents a challenge due to limited antibiotic options. …”
    Get full text
    Article
  3. 5143

    Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy by S. N. Mekhdiyev, O. A. Mekhdieva, O. M. Berko

    Published 2022-12-01
    “…Treatment of FGID includes adjustment of risk factors and drug therapy. As a pathogenetically justified pharmacotherapy of overlap syndrome, Kolofort, highly diluted antibodies to TNF-α, histamine and brain-specific protein S-100, is of interest.Conclusion. …”
    Get full text
    Article
  4. 5144

    Co-opting the ‘public’ in public health: homelessness and the specious logic of discretionary displacement in a mid-sized US city by Lesley Jo Weaver, Claire W. Herbert, Dylan J. Podrabsky, Mackenzie L. Ní Flainn

    Published 2025-12-01
    “…We find that authorities draw on sensationalized ‘disease-model’ logics of health risk that pathologize PEH as vectors of infectious disease and drug-related harms. This approach allows authorities to rationalize their decisions to displace, but it locates responsibility for the social challenge of homelessness on homeless people themselves, without providing any resources to mitigate ostensible public health concerns for either PEH or the larger public. …”
    Get full text
    Article
  5. 5145

    The potential of Dayak tribal herbal leaves as an anti-breast cancer agent: In silico approach by Kellik Setiawan Volta, Affan Ali Murtadlo Ahmad, Nur Muhammad Ansori Arif, Dhea Kharisma Viol, Dayu Rahma Turista Dora

    Published 2025-01-01
    “…Molecular docking analysis demonstrated that Quercetin and Eleutherol exhibit high binding affinities (−9 and −8 kcal/mol, respectively) with target proteins, indicating significant potential for inhibiting cancer cell proliferation by targeting proteins like EGFR, JNK, and NUDT5. The drug-likeness analysis confirmed that Quercetin and Eleutherol meet criteria for further therapeutic exploration. …”
    Get full text
    Article
  6. 5146

    Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings by Wirach Maek-a-Nantawat, Anchalee Avihingsanon, Pirapon June Ohata

    Published 2012-01-01
    “…Most of the patients infected with hepatitis C in Thailand have genotype 3 which is significantly related to intravenous drug use whereas, in Vietnam, it is genotype 6. The options for antiretroviral drugs are limited and rely on global funds and research facilities. …”
    Get full text
    Article
  7. 5147

    Biogenic Synthesis of Copper and Silver Nanoparticles Using Green Alga Botryococcus braunii and Its Antimicrobial Activity by Anju Arya, Khushbu Gupta, Tejpal Singh Chundawat, Dipti Vaya

    Published 2018-01-01
    “…The spread of infectious diseases and the increase in the drug resistance among microbes has forced the researchers to synthesize biologically active nanoparticles. …”
    Get full text
    Article
  8. 5148

    Understanding metastasis mixed-treatment responses through genomic analyses by Susana Garcia-Recio, Paola Zagami, Brooke M. Felsheim, Amy Wheless, Kerry Thomas, Renato Trimarchi, Lisa A. Carey, Charles M. Perou

    Published 2025-01-01
    “…Response to therapy in metastatic breast cancer patients with multiple metastases can also be heterogeneous, with different degrees of responsiveness to the same drug(s) across metastatic sites, termed “mixed response,” within the same patient. …”
    Get full text
    Article
  9. 5149

    Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature by Ravish Parekh, Nirmal Kaur

    Published 2014-01-01
    “…Liver injury secondary to TNF-α antagonist is an underrecognized, important clinical entity with potentially serious consequences. The mechanism of drug-induced injury is idiosyncratic. Larger cohort studies are needed to establish risk factors and injury patterns related to hepatotoxicity in these patients.…”
    Get full text
    Article
  10. 5150

    Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD by Jiahui Lin, Guowei Wang, Sha Cheng, Yanan Hu, Huan Li, Wanjiang Feng, Xiaoming Liu, Canxia Xu

    Published 2023-01-01
    “…The relationship of DLD with immune microenvironment immunomodulators, immune checkpoints, tumor mutational load (TMB), microsatellite instability (MSI), and oncology drug sensitivity was explored by correlation analysis. …”
    Get full text
    Article
  11. 5151

    Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan by Musko Monika, Sznitowska Malgorzata

    Published 2014-12-01
    “…Available tablets or capsules for adults are often used to prepare extemporaneously formulated medicines appropriate for children. The most acceptable drug forms in pediatric population are oral liquids and pharmacists use commercial dispersing media to compound syrups from an active substance or from tablets available on the market. …”
    Get full text
    Article
  12. 5152

    High-Throughput Screening and Molecular Dynamics Simulation of Natural Products for the Identification of Anticancer Agents against MCM7 Protein by Xin Zhang, Hui Chen, Hui Lin, Ronglan Wen, Fan Yang

    Published 2022-01-01
    “…Here, we present the findings of methods that used a combination of structure-assisted drug design, high-throughput virtual screening, and simulations studies to swiftly generate lead compounds against MCM7 protein. …”
    Get full text
    Article
  13. 5153

    Dasatinib and FLAG-IDA Is an Effective Therapy for Initial Myeloid Blast Crisis but Involves a High Risk of Opportunistic Infections by Jorge Labrador, Gerardo J. Hermida, Rodolfo Alvarez, Victor Anso, Pilar de Vicente, Mercedes Goñi, Tomas Jose Gonzalez-Lopez

    Published 2020-01-01
    “…However, there are no published studies or case reports supporting the use of dasatinib as first line treatment for initial myeloid BC, and very little is known about infectious complications associated with this drug. Based on this, we present the case of a patient diagnosed with an initial nonlymphoid phenotype BC, who achieved molecular response (MR4.5) with dasatinib and FLAG-IDA, but he suffered a pulmonary aspergillosis, CMV infection, and a CMV reactivation, prior to an allogeneic hematopoietic stem cell transplantation (HSCT). …”
    Get full text
    Article
  14. 5154

    Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy by Renukadevi J, Sam Helinto J, Prena D

    Published 2025-01-01
    “…Although the formulation of probiotic species in advanced drug delivery systems, such as niosomes and liposomes, may prove to be successful, regulatory guidelines need to be followed to support their nontoxic effects in preclinical trials followed by clinical studies. …”
    Get full text
    Article
  15. 5155

    Antithrombotic Medication for Cardioembolic Stroke Prevention by M. Àngels Font, Jerzy Krupinski, Adrià Arboix

    Published 2011-01-01
    “…The later exhibit stable pharmacokinetics obviating the need for coagulation monitoring or dose titration, and they lack clinically significant food or drug interaction. Moreover, they offer another potential that includes fixed dosing, oral administration, and rapid onset of action. …”
    Get full text
    Article
  16. 5156

    Inertial Memory Effects in Molecular Transport Across Nanoporous Membranes by Slobodanka Galovic, Milena Čukić, Dalibor Chevizovich

    Published 2025-01-01
    “…These findings have significant implications for understanding cell physiology, developing drug delivery systems, and designing nanoporous membranes for various applications.…”
    Get full text
    Article
  17. 5157

    NEGLECTED COXITIS TUBERCULOSA MANAGEMENT IN CHILDREN by Sulis Bayusentono, Erwin Ramawan, Henry Dominica

    Published 2019-12-01
    “…Given anti-tuberculosis drug for 12 months. In the monitoring for 2 years post-operatively, the patient reported an improvement. …”
    Get full text
    Article
  18. 5158

    Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley? by Jan Horák, Lukáš Nalos, Vendula Martínková, Jan Beneš, Milan Štengl, Martin Matějovič

    Published 2017-01-01
    “…Given the extreme complexity of sepsis pathogenesis, the paradigm “one disease, one drug” is obviously flawed and combinations of multiple targets that involve early immunomodulation and cellular protection are needed. …”
    Get full text
    Article
  19. 5159

    Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker by Hang Yi, Yiwen Lin, Yutong Li, Yeqi Guo, Ligong Yuan, Yousheng Mao

    Published 2022-01-01
    “…Additionally, the sensitivity of 9 drugs was correlated with the expression of B4GALNT1. …”
    Get full text
    Article
  20. 5160

    Helicobacter pylori: From Bench to Bedside by N Chiba, A Matisko, P Sinclair, ABR Thomson

    Published 1997-01-01
    “…However, the role of H pylori in contributing to nonulcer dyspepsia or nonsteroidal anti-inflammatory drug gastropathy remains controversial. …”
    Get full text
    Article